Daratumumab biosimilar (Xbrane)
达雷妥尤单抗生物类似药（Xbrane）
Report date: 2022/01/20 13:52:35
Base Information
Drug NameDaratumumab biosimilar (Xbrane)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesXbrane Biopharma Ab
China Registration ClassN/A
Develop Information
Other Information
ATC CodeN/A
Related LinksN/A